Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.


Treatment of Neurocysticercosis

Wednesday, June 22, 2005 - Thursday, June 23, 2005
El Pueblo Hotel, Lima, Peru

Cysticercosis, the most common cause of adult onset epilepsy in the third world, is due to infection with the cystic larval form of the intestinal-dwelling tapeworm, Taenia solium. A conference on the treatment of neurocysticercosis was particularly opportune because the recent publication in the New England Journal of Medicine of a blinded, controlled randomized treatment trial of parenchymal cysticercosis unequivocally demonstrated a medical benefit of treatment. This study added to a body of evolving evidence that treatment is medically indicated. A conference to reassess the scientific bases of treatment, to determine what is known and not known, and to design trials or studies to answer questions was timely. The goals of this scientific conference were to critically evaluate the knowledge upon which treatment decisions are based in the various forms of cysticercosis; to define gaps in knowledge; and to suggest studies, trials, or approaches that are required to answer the most pressing questions. NEUROLOGY 2006;67:1120–1127

Theodore E. Nash, M.D. (301) 496-6920

Co-funding Institute(s):
National Institute of Allergy and Infectious Diseases

From the National Center for Advancing Translational Sciences

From the National Institutes of Health

Connect with ORDR

See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.